China’s international image took a blow in the early days of the Covid-19 outbreak, due to allegations of an official cover-up of the disease in Wuhan. Soon afterwards, the Chinese government sought to restore its reputation by encouraging companies to send masks and personal protective equipment to many other nations. This was followed by a wave of vaccine diplomacy. Millions of people in China and other nations have received Chinese jabs. Yet regulators in the US, Britain and the EU have turned down the Chinese vaccines, dismissing them as ineffective or even potentially dangerous. Stephen Chan, Professor of World Politics at SOAS, talks about China’s healthcare policy in this episode of the China In Context podcast, hosted by Duncan Bartlett, Editor of Asian Affairs magazine.

China In Context: Episode 16
Broadcast date: May 25th, 2021

________________________________________

The views and opinions expressed on this podcast are those of the speakers and are not necessarily those of the SOAS China Institute.
________________________________________

SOAS China Institute (SCI)

________________________________________

Music credit: Sappheiros / CC BY 3.0

How effective is China’s vaccine diplomacy?